[go: up one dir, main page]

CN1943712B - A Chinese traditional medicinal composition for treatment of astriction and its preparation method - Google Patents

A Chinese traditional medicinal composition for treatment of astriction and its preparation method Download PDF

Info

Publication number
CN1943712B
CN1943712B CN2005101059535A CN200510105953A CN1943712B CN 1943712 B CN1943712 B CN 1943712B CN 2005101059535 A CN2005101059535 A CN 2005101059535A CN 200510105953 A CN200510105953 A CN 200510105953A CN 1943712 B CN1943712 B CN 1943712B
Authority
CN
China
Prior art keywords
weight portion
chinese medicine
medicine composition
weight
time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN2005101059535A
Other languages
Chinese (zh)
Other versions
CN1943712A (en
Inventor
刘国飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HARBIN YIZHOU PHARMACEUTICAL CO Ltd OF YUANDA PHARMACEUTICAL GROUP
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2005101059535A priority Critical patent/CN1943712B/en
Publication of CN1943712A publication Critical patent/CN1943712A/en
Application granted granted Critical
Publication of CN1943712B publication Critical patent/CN1943712B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

本发明公开了一种治疗小儿便秘的中药组合物,该组合物是由肉苁蓉、火麻仁、当归、麦冬、枳壳、莱菔子(炒)、玄参、栀子按一定工艺制备而得,适用于功能性便秘;同时,本发明还公开了该中药组合物的制备方法。The invention discloses a traditional Chinese medicine composition for treating constipation in children. The composition is prepared from Cistanche Herba, Hemp Seed, Angelica, Ophiopogon japonicus, Fructus Citrus Fructus Citrus Fructus, Radix Fructus Radix (stir-fried), Scrophulariae Scrophulariae and Gardeniae according to a certain process. , which is suitable for functional constipation; meanwhile, the invention also discloses a preparation method of the traditional Chinese medicine composition.

Description

一种治疗便秘的中药组合物及其制备方法A kind of traditional Chinese medicine composition for treating constipation and preparation method thereof

技术领域 technical field

本发明涉及一种治疗功能性便秘的中药组合物及其制备方法,属中药领域。The invention relates to a traditional Chinese medicine composition for treating functional constipation and a preparation method thereof, belonging to the field of traditional Chinese medicines.

背景技术 Background technique

小儿便秘是指婴幼儿大便异常干硬,引起排便困难的患儿排便时会因肛门疼痛而哭闹不安,多日便秘的小儿还会出现精神、食欲不好、腹胀等症。便秘不仅给小儿带来痛苦,给父母们也带来极在的一安和烦恼。引起便秘的原因很多,一般而言,便秘主要与喂养方式、饮食的质和量、排便习惯、胃肠道消化吸收能力、腹肌压力、肠道平滑肌的发育和推动力有关。人工喂养儿较母乳喂养容易便秘,这是因为牛奶中含有更多的钙和酪蛋白,而糖和淀粉含量相对减少,食入后容易形成钙皂引起便秘;生活没有规律,对婴儿没有训练成按时排便的习惯,也易此起便秘;有些慢性病症如佝偻病、皮肌炎等导致营养不良也元气引起便秘。因此,探索一种治疗小儿便秘的药物非常必要。Constipation in children refers to abnormal dry and hard stools in infants and young children. Children with difficulty in defecation will cry and be disturbed by anal pain during defecation. Children who have been constipated for many days may also experience symptoms such as spirit, poor appetite, and abdominal distension. Constipation not only brings pain to children, but also brings great peace and trouble to parents. There are many reasons for constipation. Generally speaking, constipation is mainly related to feeding methods, quality and quantity of diet, defecation habits, digestion and absorption capacity of the gastrointestinal tract, abdominal muscle pressure, development and driving force of intestinal smooth muscle. Compared with breastfeeding, artificially fed infants are prone to constipation. This is because milk contains more calcium and casein, while the content of sugar and starch is relatively less. After ingestion, it is easy to form calcium soap and cause constipation. Irregular life has no training for infants. The habit of defecating on time can also easily cause constipation; some chronic diseases such as rickets, dermatomyositis, etc. lead to malnutrition and also cause constipation. Therefore, it is very necessary to explore a drug for treating constipation in children.

发明内容 Contents of the invention

本发明的目的是提供一种制备治疗便秘的中药组合物及其制备方法。The object of the present invention is to provide a Chinese medicinal composition for treating constipation and a preparation method thereof.

本发明目的是通过如下技术方案实现的:The object of the invention is achieved through the following technical solutions:

首先是处方组成,包括如下重量份的原料药:The first is the composition of the prescription, including the following bulk drugs in parts by weight:

肉苁蓉100~300重量份    火麻仁100~200重量份    当归100~200重量份Cistanche 100-300 parts by weight 100-200 parts by weight of hemp seed 100-200 parts by weight of angelica

麦冬50~150重量份       枳壳50~150重量份       莱菔子(炒)50~150重量份50-150 parts by weight of Ophiopogon japonicus 50-150 parts by weight of Citrus aurantium 50-150 parts by weight of radish seed (stir-fried)

玄参50~150重量份       栀子50~150重量份Scrophulariaceae 50-150 parts by weight Gardenia 50-150 parts by weight

进一步研究后,确定其最佳组成为:After further research, it was determined that its optimal composition was:

肉苁蓉200重量份         火麻仁150重量份         当归150重量份Cistanche 200 parts by weight 150 parts by weight of hemp seeds 150 parts by weight of angelica

麦冬100重量份           枳壳100重量份           莱菔子(炒)100重量份100 parts by weight of Ophiopogon japonicus 100 parts by weight of Citrus aurantium 100 parts by weight of radish seed (stir-fried)

玄参100重量份           栀子100重量份100 parts by weight of Radix Scrophulariae 100 parts by weight of Gardenia

就该处方,发明认为可以制成临床所需口服液、颗粒剂、片剂、胶囊剂。针对于此,发明人又进行了工艺研究。其过程如下:With regard to this prescription, the invention thinks that it can be made into clinically required oral liquid, granules, tablets, and capsules. For this, the inventor has carried out technological research again. The process is as follows:

取原料药,加水10倍量煎煮二次,第一次2小时,第二次1.5小时,合并煎液,滤过,滤液浓缩至相对密度为1.20~1.25(70~80℃)的清膏,放冷,加乙醇使含醇量为65%,充分搅拌,静置,分取上清液,回收乙醇至无醇味,即得。Take the raw material drug, add 10 times the amount of water and decoct twice, the first time for 2 hours, the second time for 1.5 hours, combine the decoction, filter, and concentrate the filtrate to a clear paste with a relative density of 1.20-1.25 (70-80°C) , let it cool, add ethanol to make the alcohol content to 65%, fully stir, let it stand, separate the supernatant, recover the ethanol until it has no alcohol smell, and get final product.

具体实施方式:Detailed ways:

本发明药物适用于功能性便秘。发明人根据其功能主治,从润肠通便方面对其药效学进行了验证。The medicine of the present invention is suitable for functional constipation. According to its functions and indications, the inventor has verified its pharmacodynamics from the aspects of laxative and laxative.

药品  小儿便秘中药,自制。Drugs Chinese medicine for children with constipation, self-made.

复方地芬诺酯片(致便秘剂):江苏武进市武进制药厂生产,规格2.5mg/片。Compound diphenoxylate tablet (constipating agent): produced by Wujin Pharmaceutical Factory in Wujin City, Jiangsu Province, specification 2.5mg/tablet.

动物  昆明种小鼠,体重18~22g,雌雄兼用,由北京大学医学院实验动物部提供。Animals Kunming mice, weighing 18-22 g, of both sexes, were provided by the Experimental Animal Department of Peking University School of Medicine.

方法method

试验1对正常小鼠的排便影响Effect of test 1 on the defecation of normal mice

正常小鼠40只,禁食6h,随机分成4组,每组10只,各组分别以高(8ml/kg)、中(4ml/kg)、低(2ml/kg)剂量小儿秘通口服液(分别稀释为10ml,下同)及生理盐水灌胃,给药后连续观察每只动物7h粪便粒数,粪便重量,第1次排出黑便时间,采用t检验比较各组动物上述指标的差异。40 normal mice, fasted for 6 hours, were randomly divided into 4 groups, 10 in each group, each group received high (8ml/kg), medium (4ml/kg) and low (2ml/kg) doses of Xiaoer Mitong Oral Liquid (respectively diluted to 10ml, the same below) and intragastric administration of normal saline. After the administration, the number of feces grains, the weight of feces, and the time of the first discharge of black stool were observed continuously for 7 hours after administration, and the differences in the above indicators of the animals in each group were compared by t test. .

表1对正常小鼠排便的影响(X±s) The impact of table 1 on the defecation of normal mice (X ± s)

注:与生理盐水组比较P<0.05。Note: P<0.05 compared with normal saline group.

试验2对抗地芬诺酯抑制肠推进作用试验Test 2 Antidiphenoxylate Inhibition of Intestinal Propulsion Test

小鼠50只雌雄兼用,随机分为5组,每组10只,按剂量设计方法连续喂养25天。末天禁食12h后,A组用生理盐水,C、D、E组用低、中、高剂量中药口服液灌胃1次,20min后,B、C、D、E组用地芬诺酯50mg/kg灌胃,10min后各组用炭末悬液按0.1ml/10g灌胃。20min后将小鼠处死开腹,取小肠,测量炭末推进长度及小肠全长,计算炭末推进移动率。Fifty mice of both sexes were randomly divided into 5 groups, 10 in each group, and fed continuously for 25 days according to the dosage design method. After 12 hours of fasting on the last day, group A received normal saline, and groups C, D and E received oral administration of low, medium and high doses of traditional Chinese medicine once, and after 20 minutes, groups B, C, D and E received 50 mg of diphenoxylate After 10 minutes, each group was gavaged with charcoal powder suspension at 0.1ml/10g. After 20 min, the mice were sacrificed and laparotomized, and the small intestines were taken, and the propulsion length of the charcoal powder and the total length of the small intestine were measured, and the propulsion mobility rate of the charcoal powder was calculated.

墨汁推进率=墨汁推进长度(cm)/小肠总长度(cm)×100%Ink propulsion rate = ink propulsion length (cm)/total length of small intestine (cm)×100%

表2对抗地芬诺酯抑制肠推进作用效果

Figure G051A5953520051013D000022
Table 2 Anti-diphenoxylate inhibits intestinal propulsion effect
Figure G051A5953520051013D000022

注:与地芬诺酯对照组比较P<0.05。Note: Compared with diphenoxylate control group, P<0.05.

实施例一Embodiment one

【处方】肉苁蓉  200g    火麻仁  150g    当归      150g[Prescription] Cistanche 200g Hemp Seed 150g Angelica 150g

        麦冬    100g    枳壳    100g    莱菔子(炒)100gOphiopogon japonicus 100g Citrus aurantium 100g Raisin seeds (stir-fried) 100g

        玄参    100g    栀子    100gScrophulariaceae 100g Gardenia 100g

【制法】取原料药,加水10倍量煎煮二次,第一次2小时,第二次1.5小时,合并煎液,滤过,滤液浓缩至相对密度为1.20~1.25(70~80℃)的清膏,放冷,加乙醇使含醇量为65%,充分搅拌,静置,分取上清液,回收乙醇至无醇味,加入蔗糖100g、蜂蜜225g、甜菊素3g,调pH值至5.0~7.0,加水至1000ml,混匀,静置,滤过,灌装,灭菌,即得。[Preparation method] Take the raw material, add 10 times the amount of water and decoct twice, the first time is 2 hours, the second time is 1.5 hours, the decoction is combined, filtered, and the filtrate is concentrated to a relative density of 1.20-1.25 (70-80°C ) clear paste, let it cool, add ethanol to make the alcohol content 65%, fully stir, stand still, separate the supernatant, recycle the ethanol until there is no alcohol smell, add 100g of sucrose, 225g of honey, 3g of stevia, adjust the pH When the value reaches 5.0-7.0, add water to 1000ml, mix well, let it stand, filter, fill, sterilize, and get ready.

实施例二Embodiment two

【处方】肉苁蓉  400g    火麻仁  300g    当归      300g[Prescription] Cistanche 400g Hemp Seed 300g Angelica 300g

        麦冬    200g    枳壳    200g    莱菔子(炒)200gOphiopogon japonicus 200g Citrus aurantium 200g Raisin seeds (fried) 200g

        玄参    200g    栀子    200gScrophulariaceae 200g Gardenia 200g

【制法】取原料药,加水10倍量煎煮二次,第一次2小时,第二次1.5小时,合并煎液,滤过,滤液浓缩至相对密度为1.20~1.25(70~80℃)的清膏,放冷,加乙醇使含醇量为65%,充分搅拌,静置,分取上清液,回收乙醇至无醇味,浓缩至相对密度为1.10(60℃),喷雾干燥,加蔗糖至总量为1000g,干压制粒,即得。[Preparation method] Take the raw material, add 10 times the amount of water and decoct twice, the first time is 2 hours, the second time is 1.5 hours, the decoction is combined, filtered, and the filtrate is concentrated to a relative density of 1.20-1.25 (70-80°C ) clear paste, let it cool, add ethanol to make the alcohol content 65%, fully stir, stand still, separate the supernatant, recover the ethanol until there is no alcohol smell, concentrate to a relative density of 1.10 (60°C), and spray dry , add sucrose until the total amount is 1000g, and dry-press granules to obtain the product.

Claims (4)

1. Chinese medicine composition is characterized in that this Chinese medicine composition made by following raw material medicaments:
Herba Cistanches 100~300 weight portion Fructus Cannabiss 100~200 weight portion Radix Angelicae Sinensis 100~200 weight portions
Radix Ophiopogonis 50~150 weight portion Fructus Aurantiis, 50~150 weight portion Semen Raphani (parched), 50~150 weight portions
Radix Scrophulariae 50~150 weight portion Fructus Gardeniaes 50~150 weight portions
Preparation method is as follows:
Get crude drug, decoct with water 1-3 time, each 1-3 hour, collecting decoction filtered, it is 1.20~1.25 clear paste that filtrate is concentrated in the time of 70~80 ℃ relative density, puts coldly, adds ethanol and makes and contain the alcohol amount and be 60-70%, fully stirs, leave standstill, divide and get supernatant, reclaim ethanol to there not being the alcohol flavor, promptly.
2. Chinese medicine composition as claimed in claim 1 is characterized in that this Chinese medicine composition made by following bulk drugs:
Herba Cistanches 200 weight portion Fructus Cannabiss 150 weight portion Radix Angelicae Sinensis 150 weight portions
Radix Ophiopogonis 100 weight portion Fructus Aurantiis, 100 weight portion Semen Raphani (parched), 100 weight portions
Radix Scrophulariae 100 weight portion Fructus Gardeniaes 100 weight portions.
3. Chinese medicine composition as claimed in claim 1 is characterized in that said composition can be made into clinical required oral liquid, granule, tablet, capsule.
4. Chinese medicine composition as claimed in claim 1 is characterized in that preparation method is as follows: get crude drug, add 10 times of amounts of water and decoct secondary, 2 hours for the first time, 1.5 hours for the second time, collecting decoction, filter, it is 1.20~1.25 clear paste that filtrate is concentrated in the time of 70~80 ℃ relative density, puts cold, add ethanol and make that to contain alcohol amount be 65%, fully stir, leave standstill, divide and get supernatant, reclaim ethanol to there not being the alcohol flavor, promptly.
CN2005101059535A 2005-10-08 2005-10-08 A Chinese traditional medicinal composition for treatment of astriction and its preparation method Expired - Lifetime CN1943712B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2005101059535A CN1943712B (en) 2005-10-08 2005-10-08 A Chinese traditional medicinal composition for treatment of astriction and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2005101059535A CN1943712B (en) 2005-10-08 2005-10-08 A Chinese traditional medicinal composition for treatment of astriction and its preparation method

Publications (2)

Publication Number Publication Date
CN1943712A CN1943712A (en) 2007-04-11
CN1943712B true CN1943712B (en) 2011-12-14

Family

ID=38043506

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005101059535A Expired - Lifetime CN1943712B (en) 2005-10-08 2005-10-08 A Chinese traditional medicinal composition for treatment of astriction and its preparation method

Country Status (1)

Country Link
CN (1) CN1943712B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101837053A (en) * 2010-05-28 2010-09-22 中国人民解放军总医院 Chinese medicinal composition and preparation for loosening bowel and relieving constipation and preparation method thereof
CN103053905B (en) * 2013-01-16 2014-01-29 无限极(中国)有限公司 Health-care food with constipation improvement function

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1076618A (en) * 1992-06-15 1993-09-29 中国人民解放军空军南京医院 " shenshenwan " of treatment constipation
CN1095932A (en) * 1993-05-29 1994-12-07 陆国钧 Laxative traditional Chinese medicine capable of reducing free radical level of human body
CN1234248A (en) * 1999-01-15 1999-11-10 陆国钧 Chinese-medicine and without laxative for relaxing bowels
CN1342476A (en) * 2000-09-14 2002-04-03 浙江省中药研究所 Chinese medicine for nourishing Yin and treating constipation
CN1481870A (en) * 2003-07-24 2004-03-17 黄资源 Compound traditional Chinese medicine preparation for treating intractable chronic constipation and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1076618A (en) * 1992-06-15 1993-09-29 中国人民解放军空军南京医院 " shenshenwan " of treatment constipation
CN1095932A (en) * 1993-05-29 1994-12-07 陆国钧 Laxative traditional Chinese medicine capable of reducing free radical level of human body
CN1234248A (en) * 1999-01-15 1999-11-10 陆国钧 Chinese-medicine and without laxative for relaxing bowels
CN1342476A (en) * 2000-09-14 2002-04-03 浙江省中药研究所 Chinese medicine for nourishing Yin and treating constipation
CN1481870A (en) * 2003-07-24 2004-03-17 黄资源 Compound traditional Chinese medicine preparation for treating intractable chronic constipation and preparation method thereof

Also Published As

Publication number Publication date
CN1943712A (en) 2007-04-11

Similar Documents

Publication Publication Date Title
WO2013010383A1 (en) Intestine-hydrating and laxative drink and preparation method therefor
CN104107188B (en) Apple polysaccharide adjusts intestinal bacilli illness and the purposes to relax bowel and preparation method thereof
CN102696948B (en) Constipation improving food and preparation method thereof
CN105596605A (en) Composition with bowel relaxing and sleep improving functions and preparation method thereof
CN102429183B (en) Fruit and vegetable composition with immunity enhancing and bowel relaxing functions and preparation method thereof
CN104983902A (en) Traditional Chinese medicine composition for treating insomnia and dreaminess and preparation method and application thereof
CN113425817B (en) Traditional Chinese medicine composition for strengthening spleen and stomach and promoting digestion and removing food retention as well as preparation method and application thereof
KR101149431B1 (en) Novel pharmaceutical composition for use as a laxative
CN1943712B (en) A Chinese traditional medicinal composition for treatment of astriction and its preparation method
CN102038857B (en) Method for preparing Chinese medicinal composition for treating child dyspepsia caused by overeating
CN108245531B (en) Composition for improving gastrointestinal tract function and preventing and treating constipation
WO2014154008A1 (en) Purgative composition, preparation method therefor and application thereof
CN111000951A (en) Chinese medicinal preparation for treating indigestion and abdominal distention and preparation process thereof
CN107714936A (en) A kind of Chinese medicine composition and preparation method and application
CN104757549B (en) One kind relaxes bowel composition
CN102614426B (en) A kind of medicinal preparation for digestion and stagnation
CN116350724A (en) A kind of traditional Chinese medicine preparation capable of regulating intestines and stomach, removing stagnation and reducing swelling and its preparation process
CN104800789A (en) Traditional Chinese medicine composition for treating constipation and preparation method thereof
CN103598589B (en) Composition with therapy or health care effect
CN110522022B (en) Okra powder capable of relaxing bowels and preparation method of okra powder
CN102526211A (en) Composition of oral medicine for treating constipation and preparation technology
CN111297974A (en) Application of traditional Chinese medicine composition in preparation of medicine for treating food stagnation
CN119280341A (en) Composition and application for ventilation, relieving abdominal distension and abdominal pain, and improving constipation
CN120501805A (en) A composition containing aloe raw material, its preparation method and application in preparing product for improving and balancing gastrointestinal function
CN104940332A (en) Fructo oligosaccharide composition for relaxing bowels and reducing flatulence and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Fu Shangda

Inventor before: Liu Guofei

COR Change of bibliographic data
TR01 Transfer of patent right

Effective date of registration: 20151214

Address after: 150086 No. 408, Xuefu Road, Xiangfang District, Heilongjiang, Harbin

Patentee after: Harbin Yizhou Pharmaceutical Co., Ltd. of Yuanda Pharmaceutical Group

Address before: 100012, No. 10, Qinglong dragon alley, Dongcheng District, Beijing

Patentee before: Liu Guofei

C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: The 150066 auspicious clouds in Heilongjiang Province Economic and Technological Development Zone of Harbin District A Hanan Industrial Park Road No. 1

Patentee after: Harbin Yizhou Pharmaceutical Co., Ltd. of Yuanda Pharmaceutical Group

Address before: 150086 No. 408, Xuefu Road, Xiangfang District, Heilongjiang, Harbin

Patentee before: Harbin Yizhou Pharmaceutical Co., Ltd. of Yuanda Pharmaceutical Group

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20111214